- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Concurrent whole brain radiotherapy and bortezomib for brain metastasis ; volume:8 ; number:1 ; day:21 ; month:8 ; year:2013 ; pages:1-8 ; date:12.2013
Radiation oncology ; 8, Heft 1 (21.8.2013), 1-8, 12.2013
- Urheber
-
Lao, Christopher D.
- Beteiligte Personen und Organisationen
-
Friedman, Judah
Tsien, Christina I.
Normolle, Daniel P.
CHAPMAN, CHRISTOPHER
Cao, Yue
Lee, Oliver
Schipper, Matt
Van Poznak, Catherine
Hamstra, Daniel
Lawrence, Theodore
Hayman, James
Redman, Bruce G.
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-8-204
- URN
-
urn:nbn:de:1111-201604096077
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lao, Christopher D.
- Friedman, Judah
- Tsien, Christina I.
- Normolle, Daniel P.
- CHAPMAN, CHRISTOPHER
- Cao, Yue
- Lee, Oliver
- Schipper, Matt
- Van Poznak, Catherine
- Hamstra, Daniel
- Lawrence, Theodore
- Hayman, James
- Redman, Bruce G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
Role of exosomal miRNAs in brain metastasis affected by radiotherapy
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique
Correction to: Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life
Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
Liquid biopsies to occult brain metastasis
Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy
Update on the Management of Brain Metastasis
Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
Role of exosomal miRNAs in brain metastasis affected by radiotherapy
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique
Correction to: Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life
Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
Liquid biopsies to occult brain metastasis
Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy
Update on the Management of Brain Metastasis
Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
Role of exosomal miRNAs in brain metastasis affected by radiotherapy
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique
Correction to: Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life
Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
Liquid biopsies to occult brain metastasis
Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy